Genmab A/S GMAB.CO DK Equity
DKK 2,167.00
+8.00 (+0.37%)
DKK · as of 2026-08-27 · marketstack
Genmab A/S (Nasdaq Copenhagen: GMAB.CO) closed at 2,167.00 DKK, +0.4%, on 2026-08-27, with a return on equity of 17.5%, a net margin of 25.9% and 3-year sales growth of -36.5%. Institutional ownership, earnings history and filed financials are on the tabs below.
Short interest· FINRA consolidated · settlement 2026-08-14· GMABGENMAB A/S
6 settlement cyclesShort interest shown for the US-listed sibling GMAB — FINRA covers US listings; figures are that line's shares.
| Shares short | 7.6M |
| % of shares out | — |
| Days to cover | 2.7 |
| Δ vs 2026-07-31 | +2.8% |
bars = shares short · line = days to cover (own scale)
% of shares outstanding suppressed: the listed line's share basis (ADR/depositary) differs from the reported ordinary share count.
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.